Industry News
Pharmaceutical Industry News
SK Life Science kicks Xcopri sales into high gear with new campaign
SK Life Science kicks Xcopri sales into high gear with new campaign sharon.coey Mon, 05/23/2022 - 10:51
GSK dodges UK strike with improved pay offer for staffers
GSK dodges UK strike with improved pay offer for staffers fkansteiner Mon, 05/23/2022 - 10:49
Pharma bucks trend, shunning digital and sticking with TV when it comes to ads
Pharma bucks trend, shunning digital and sticking with TV when it comes to ads badams Mon, 05/23/2022 - 10:38
Pfizer, BioNTech tout COVID booster data for young children and plan to finish FDA filing
Pfizer, BioNTech tout COVID booster data for young children and plan to finish FDA filing zbecker Mon, 05/23/2022 - 10:09
Monkeypox outbreak won’t be the next global pandemic thanks to vaccines, drugs: analysts
Monkeypox outbreak won't be the next global pandemic thanks to vaccines, drugs: analysts aliu Mon, 05/23/2022 - 10:07
FDA lifts hold on Ocugen’s COVID-19 vaccine trial. But is it too late for the shot?
FDA lifts hold on Ocugen's COVID-19 vaccine trial. But is it too late for the shot? kdunleavy Mon, 05/23/2022 - 09:16
Merck KGaA lines up 370 new jobs with $470M manufacturing boost in Ireland
Merck KGaA lines up 370 new jobs with $470M manufacturing boost in Ireland fkansteiner Mon, 05/23/2022 - 08:29
Vir, WuXi Biologics terminate COVID antibody pact as US rollout faces uncertain future
Vir, WuXi Biologics terminate COVID antibody pact as US rollout faces uncertain future aliu Mon, 05/23/2022 - 07:26
Doctors Gave Her Antipsychotics. She Decided to Live With Her Voices.
A new movement wants to shift mainstream thinking away from medication and toward greater acceptance.
Sanofi’s Dupixent scores big as the first FDA-approved treatment for eosinophilic esophagitis
Sanofi's Dupixent scores big as the first FDA-approved treatment for eosinophilic esophagitis zbecker Fri, 05/20/2022 - 15:45
Help With Medicare Costs: What You Need to Know
Low-income Americans on Medicare can get assistance paying their premiums and other expenses. Several states have allowed more people to qualify.
Sanofi’s Xenpozyme, Lilly’s Olumiant among batch of new EU approvals
Sanofi's Xenpozyme, Lilly's Olumiant among batch of new EU approvals kdunleavy Fri, 05/20/2022 - 10:54
Gilead Sciences nabs top HIV philanthropic fundraising spot in the US, passing Gates Foundation
Gilead Sciences nabs top HIV philanthropic fundraising spot in the US, passing Gates Foundation zbecker Fri, 05/20/2022 - 10:06
Novartis hands over Tasigna patent as part of coalition with Roche, BMS and more to boost cancer drug access in poor countries
Novartis hands over Tasigna patent as part of coalition with Roche, BMS and more to boost cancer drug access in poor countries aliu Fri, 05/20/2022 - 09:40
FDA lays out framework for manufacturers and developers to tackle drug shortages
FDA lays out framework for manufacturers and developers to tackle drug shortages fkansteiner Fri, 05/20/2022 - 09:13
Moderna CEO Stéphane Bancel, for helping slay COVID, knighted in France
Moderna CEO Stéphane Bancel, for helping slay COVID, knighted in France badams Fri, 05/20/2022 - 08:02
AbbVie faces yet another ‘white-coat’ lawsuit claiming it used kickbacks to help promote Humira
AbbVie faces yet another 'white-coat' lawsuit claiming it used kickbacks to help promote Humira kdunleavy Fri, 05/20/2022 - 07:17
Fierce Pharma Asia—Hengrui’s global plan; Merck, Kelun’s $1.4B cancer deal; Dr. Reddy’s Russia business
Fierce Pharma Asia—Hengrui's global plan; Merck, Kelun's $1.4B cancer deal; Dr. Reddy's Russia business aliu Fri, 05/20/2022 - 06:18
A New Kind of Drug
How the country’s drug problem is changing, and why it’s growing.
Calliditas, with a fresh approval for Tarpeyo in hand, launches IgA kidney disease education campaign
Calliditas, with a fresh approval for Tarpeyo in hand, launches IgA kidney disease education campaign badams Fri, 05/20/2022 - 05:10